Alkem Laboratories News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Alkem Laboratories Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news and updates on Alkem Laboratories from all sources in a single place.

Load latest

Alkem Laboratories Ltd.

22 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release in this regard is enclosed herewith.

pdf

Alkem Laboratories Ltd.

19 Sep 2025

5638.50

0.52%

CXO 1x1: Dr. Vikas Gupta, CEO

Buy: Alkem Laboratories Ltd.

Target

ICICI Securities Limited

Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.

Alkem Laboratories Ltd.

18 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September, 2025, 26th September, 2025 and 30th September, 2025.

pdf

Alkem Laboratories Ltd.

17 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held on 22nd September, 2025.

pdf

Alkem Laboratories Ltd.

16 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 22nd September, 2025 and 25th September, 2025.

pdf

Alkem Laboratories Ltd.

09 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)- Cancellation Of Analyst / Institutional …

BSE India

In continuation to our intimation dated 03rd September, 2025, this is to inform that, the Analyst / Investor meeting as scheduled to be held on Tuesday, 09th September, 2025, has been cancelled.

pdf

Alkem Laboratories Ltd.

08 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 12th September, 2025, 17th September, 2025, 18th September, 2025, 19th September, 2025 and 23rd September, 2025.

pdf

Alkem Laboratories Ltd.

03 Sep 2025

5638.50

0.52%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meeting scheduled to be held on 09th September, 2025.

pdf

Alkem Laboratories Ltd.

25 Aug 2025

5638.50

0.52%

AGM

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Details regarding the brief proceedings of the 51st AGM and the voting results of the business transacted thereat along with the Report of the Scrutinizer on remote e-voting and e-voting during the AGM are enclosed herewith. Kindly take the same on record.

pdf

Alkem Laboratories Ltd.

25 Aug 2025

5638.50

0.52%

AGM

Alkem Laboratories Ltd - 539523 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Details regarding the brief proceedings of the 51st AGM of the Company and voting results of the business transacted thereat alongwith the report of the Scrutinizer on remote e-voting and e-voting during the AGM are enclosed herewith. Request you to kindly take the same on record.

pdf

Is Alkem Laboratories Ltd. worth buying?

140 Votes:

Buy 79.29%

Sell 14.29%

Hold 6.43%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf